GSK Survey Finds Consumers “Confused” By Weight-Loss Drugs, Supplements
This article was originally published in The Tan Sheet
Executive Summary
A survey commissioned by GlaxoSmithKline shows that many consumers are "confused" about the safety and regulation of dietary supplements for weight loss
You may also be interested in...
Petition Requests Pre-Market Approval For Supplement Weight-Loss Claims
Manufacturers would need pre-market approval to make weight-loss claims for supplements if FDA implements a rulemaking recommended by petitioners, including GlaxoSmithKline, the manufacturer of OTC weight-loss drug alli.
Petition Requests Pre-Market Approval For Supplement Weight-Loss Claims
Manufacturers would need pre-market approval to make weight-loss claims for supplements if FDA implements a rulemaking recommended by petitioners, including GlaxoSmithKline, the manufacturer of OTC weight-loss drug alli.
Petition Requests Pre-Market Approval For Supplement Weight-Loss Claims
Manufacturers would need pre-market approval to make weight-loss claims for supplements if FDA implements a rulemaking recommended by petitioners, including GlaxoSmithKline, the manufacturer of OTC weight-loss drug alli.